Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2025-12-25 @ 2:08 AM
NCT ID:
NCT02275260
Eligibility Criteria:
Inclusion Criteria:
* Electrocardiographically documented, symptomatic paroxysmal AF.
* Patients with indication for left atrial ablation of AF according to ESC guidelines for the management of atrial fibrillation.
* Anticoagulation according to clinical routine using coumarin derivates with target INR between 2.0 and 3.0 at least 3 weeks prior to the scheduled ablation procedure or novel oral anticoagulants (NOACs).
* Geographically stable for the duration of the study.
* Willingness and ability to perform written informed consent
Exclusion Criteria:
* Long standing persistent or persistent AF
* CHA2DS2-VASc score ≥ 5
* Prior ischemic stroke or Transient Ischemic Attack
* Previous Pulmonary Vein ablation
* Contraindication for anticoagulation therapy
* Contraindication for Diffusion-Weighted MRI
* Claustrophobia
* Contraindication for transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE, if TEE not possible)
* Implanted cardiovascular device, including but not limited to an atrial or ventricular pacemaker or defibrillator leads, artificial valves, stents, septal or LAA occluders
* Acute coronary syndrome \< 3 months prior to scheduled ablation
* Moderate to severe valvular heart disease
* LA size \> 55 mm (confirming echo at maximum 3 months old)
* Patients with non-controlled heart failure or patients with current and recent (\< 1 month prior to ablation) heart failure
* Ejection fraction \< 35% (confirming echo at maximum 3 months old)
* Conditions that prevent patient's participation in neurocognitive assessment (at physician's discretion)
* Female patients who are pregnant or breast feeding or plan a pregnancy during the course of the study
* Any limitation to contractual capability
* Simultaneous participation in another study
* Age \< 18 years
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02275260
Study Brief:
Protocol Section:
NCT02275260